Effect of desmethylimipramine, protriptyline and (+)-amphetamine on fluorescence of central adrenergic neurons of rats pretreated with alpha-methyl-DOPA and tetrabenazine or reserpine.
D000661:Amphetamine / Q000494:pharmacology*; D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology*; D001522:Behavior, Animal / Q000187:drug effects; D001921:Brain / Q000166:cytology / Q000378:metabolism*; D003891:Desipramine / Q000494:pharmacology*; D005453:Fluorescence; D006651:Histocytochemistry; D008297:Male; D008750:Methyldopa / Q000494:pharmacology*; D008856:Microscopy, Fluorescence; D006899:Mixed Function Oxygenases / Q000037:antagonists & inhibitors; D009638:Norepinephrine / Q000096:biosynthesis; D009647:Normetanephrine / Q000378:metabolism*; D051381:Rats; D012110:Reserpine / Q000494:pharmacology*; D013564:Sympathetic Nervous System / Q000187:drug effects / Q000378:metabolism*; D013747:Tetrabenazine / Q000494:pharmacology*
D000928:Antidepressive Agents; D009647:Normetanephrine; D008750:Methyldopa; D012110:Reserpine; D000661:Amphetamine; D006899:Mixed Function Oxygenases; D003891:Desipramine; D009638:Norepinephrine; D013747:Tetrabenazine